Engineered nanomaterials (ENs, particles < 100 nm) offer tremendous opportunities in industry, daily consumables, medicine, electronics and numerous other areas. However, there are considerable knowledge gaps concerning the potential hazardous effects of ENs on human health and the environment. The NANOMMUNE partnership is committed to filling these knowledge gaps through a comprehensive assessment of ENs, with particular focus on effects on the immune system.
Through our comprehensive approach, which combines different disciplines, we aim to analyze and predict the toxic potential of existing and emerging ENs on key functions of the immune system. A detailed physico-chemical characterization of ENs is also an integrative part of the project. Overall, the NANOMMUNE project results will enhance the understanding of possible adverse effects of nanomaterials and will contribute to a continuous and sustainable growth of the nanotechnologies.
The NANOMMUNE project was launched on September 1st 2008 and will run for 3 years. The project is funded by the European Commission through the 7th Framework Programme by the funding scheme of Collaborative projects, in the area of Nanosciences, Nanotechnologies, Materials and New Production Technologies (NMP).